Induction of antitumor immunity using bone marrow-generated dendritic cells

Journal of Immunology

Volumn 156, Issue 8, 1996, Pages 2918-2926

  Porgador, Angel ^a,b   Snyder, David ^a   Gilboa, Eli ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Institute of Cancer Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; OVALBUMIN;

ANIMAL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW; C3H MOUSE; C57BL MOUSE; CELL CULTURE; CROSS BREEDING; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; FEMALE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; THYMOMA;

ANIMALS; ANTIGEN PRESENTATION; BONE MARROW; CROSSES, GENETIC; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; OVALBUMIN; T-LYMPHOCYTES, CYTOTOXIC; THYMOMA; TUMOR CELLS, CULTURED;

EID: 0030584839     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hamaoka, T , and H. Fujiwara, 1987. Phenotypically and functionally distinct T cell subsets in anti-tumor responses, Immunol, Today 8:267.
2. Greenberg, P D 1991. Adoptive T cell therapy of tumors, mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49,281
3. Bevan, M. J. 1987. Class discrimination in the world of immunology Nature 325:192.
4. Lafferty, K. J., S. J Prowse, C. J. Simeonovic, and H. S. Warren, 1983. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu. Rev. Immunol 1:143.
5. Bannerji, R., C. D. Arroyo, C. Cordon-Cardo, and E. Gilboa 1994 The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity J. Immunol. 152:2324.
6. Huang, A. Y C , P Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky, 1994. Role of bone marrow-derived cells in presenting MHC class I-restncted tumor antigens Science 264:961.
7. Steinman, R M 1991. The dendritic cell system and its role in immunogenicity Annu. Rev Immunol 9:271.
8. Nair, S., J. S. Babu, R. G Dunham, P. Kanda, R. L Burke, and B. T. Rouse, 1993 Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells, J. Virol 67:4062.
9. Rouse, R J. D., S. K. Narr, S L. Lydy, J. C. Bowen, and B T. Rouse, 1994. Induction in vitro of primary cytotoxic T-lymphocytes responses with DNA encoding herpes simplex virus proteins. J Virol. 68:5685
10. McKinney, E C., and I. W. Streilein. 1989 On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo. J. Immunol 143:1560
11. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol. 5:849.
12. Shimizu, J., T. Suda, T. Yoshioka, A. Kosugi, H. Fujiwara, and T. Hamaoka, 1989. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. J. Immunol 142:1053.
13. Grabbe, S., S Bruvers, R. L. Gallo, T. L Knisely, R. Nazareno, and R. D. Granstein. 1991. Tumor antigen presentation by murine epidermal cells. J. Immunol. 146:3656.
14. Flamand, V., T. Somasse, K. Thielemans, C. Demanet, M. Bakkus, H Bazin, F. Tielemans, O. Leo, J. Urgain, and M. Moser, 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605.
15. Inaba, K., M. Inaba, N. Romani, H. Aya, S. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman, 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
16. Inaba, K., M. Inaba, M. Naito, and R. M. Steinman, 1993. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med 178:479.
17. Porgador, A., and E. Gilboa, 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes J. Exp. Med. 182:255.
18. Moore, M. W., F. R. Carbone, and M J. Bevan. 1988 Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
19. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee, 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891.
20. Mandelboim, O., G. Berke, M. Fridkin, M. Feldman, M. Eisenstein, and L. Eisenbach, 1994. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67.
21. Volgmann, T., A. Klein-Struckmeier, and H. Mohr, 1989. A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity J. Immunol. Methods 119.45
22. Rock, K. L., S. Gamble, and L. Rothstein, 1990. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918.
23. De Bruijn, M. L. H., T. N. M Schumacher, J. D. Nieland, H. L. Ploegh, W. M. Kast, and C. J M. Melief, 1991. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. Eur. J. Immunol 21,2963.
24. Franksson, L , M. Petersson, R. Kiessling, and K. Karre, 1993. Immunization against tumor and minor histocompatability antigens by eluted cellular peptides loaded on antigen processing defective cells. Eur. J. Immunol. 23,2606
25. Mayordomo, J. I , T. Zorina, W. J. Storkus, L. Zitvogel, C. Celluzzi, L. D. Falo, C. I. Melief, S. T. Ildstad, W. M. Kast, A. B. Deleo, and M. T. Lotze, 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1:1297.
26. Zinkernagel, R. M., G. N. Callahan, A. Althage, S. Cooper, J. W. Streilein, and J. Klein, 1978. The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help J. Exp. Med. 147:897.
27. Von Boehmer, H , and W. Haas, 1979. Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen. J. Exp. Med. 150:1134.
28. Keene, J., and J. Forman, 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp Med. 155:768.
29. Guerder, S., and P. Matzinger, 1992. A fail-safe mechanism for maintaining self-tolerance, J. Exp. Med. 176:553.
30. Buller, M L., K. L. Holmes, A. Hugin, T. N. Frederickson, and H. C. Morse, 1987. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328:77.
31. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:2102.
32. Gelber, C., D. Plaksin, M. Feldman, and L. Eisenbach. 1989. Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes. Cancer Res. 49,2366.
33. Nonacs, R., C. Humborg, J P. Tam, and R. M. Steinman, 1992. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes J. Exp Med 176:519.
34. Ossevoort, M A., M. C. W. Feltkamp, K. J. H van Veen, C. J. M. Melief, and W. M Kast. 1995. Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papilloma virus type 16-induced tumor. J. Immunother. 18:86.
35. Mandelboim, O., E. Vadai, M. Fridkin, A. Katz-Hillel, M. Feldman, G. Berke, and L. Eisenbach, 1995. Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides. Nat. Med. 1:1179.
36. Bellone, M., G. Iezzi, A A. Manfredi, M. P. Protti, A. Dellabona, G. Casorati, and G. Rugarli, 1994. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells. Eur. J. Immunol. 24:2691.
37. Connor, J., R. Bannerji, S. Saito, W. Heston, W. Fair, and E. Gilboa, 1993. Regression of bladder tumors in mice treated with IL-2 gene-modified tumor cells J. Exp. Med. 177.1127.
38. Porgador, A., R. Bannerji, Y. Watanabe, M. Feldman, E. Gilboa, and L. Eisenbach, 1993. Anti-metastatic vaccination of tumor-bearing mice with two types of IFN-γ gene-inserted tumor cells. J Immunol. 150:1458.
39. Vieweg, J., F. Rosenthal, R Bannerji, W. Heston, W. Fair, B. Gansbacher, and E. Gilboa, 1994. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene-modified tumor vaccines. Cancer Res. 54:1760.
40. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R. Mulligan 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci USA 90:3539.